These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 8989479)

  • 21. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.
    Frohn-Mulder IM; Stewart PA; Witsenburg M; Den Hollander NS; Wladimiroff JW; Hess J
    Prenat Diagn; 1995 Dec; 15(13):1297-302. PubMed ID: 8710768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine triphosphate for cardioversion of supraventricular tachycardia in two hydropic fetuses.
    Dangel JH; Roszkowski T; Bieganowska K; Kubicka K; Ganowicz J
    Fetal Diagn Ther; 2000; 15(6):326-30. PubMed ID: 11111211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review.
    Tunca Sahin G; Beattie RB; Uzun O
    Cardiol Young; 2022 Jul; 32(7):1077-1084. PubMed ID: 34551832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases].
    Pete B; Hajdú J; Papp Z
    Orv Hetil; 2004 Dec; 145(52):2611-7. PubMed ID: 15724696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience.
    O'Leary ET; Alexander ME; Bezzerides VJ; Drogosz M; Economy KE; Friedman KG; Pickard SS; Tworetzky W; Mah DY
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1105-1113. PubMed ID: 32100356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal study in 18 cases of fetal supraventricular tachycardia: Doppler echocardiographic findings and pathophysiologic implications.
    Gembruch U; Redel DA; Bald R; Hansmann M
    Am Heart J; 1993 May; 125(5 Pt 1):1290-301. PubMed ID: 8480580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrauterine therapy for fetal supraventricular tachycardia in a twin pregnancy.
    Tanawattanacharoen S; Uerpairojkit B; Prechawat S; Manotaya S; Charoenvidhya D
    J Obstet Gynaecol Res; 2005 Apr; 31(2):94-7. PubMed ID: 15771633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of foetal supraventricular tachycardia with antiarrhythmic medication administered through the umbilical vein].
    Roest AA; Vandenbussche FP; Klumper FJ; Oepkes D; Rijlaarsdam ME; Blom NA
    Ned Tijdschr Geneeskd; 2008 Feb; 152(7):389-92. PubMed ID: 18380387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum.
    Agarwal A; Saha SC; Kaur A; Naganur S
    BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38154874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
    Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone.
    Kang SL; Howe D; Coleman M; Roman K; Gnanapragasam J
    Cardiol Young; 2015 Mar; 25(3):447-53. PubMed ID: 24811422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resolution of hydrops fetalis despite persistent fetal tachycardia.
    Silver LE; Platt LD; Santulli TV; Carlson DE
    J Ultrasound Med; 2001 Oct; 20(10):1141-5. PubMed ID: 11587022
    [No Abstract]   [Full Text] [Related]  

  • 33. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia.
    Strizek B; Berg C; Gottschalk I; Herberg U; Geipel A; Gembruch U
    Heart Rhythm; 2016 Jun; 13(6):1283-8. PubMed ID: 26829115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia.
    Vigneswaran TV; Callaghan N; Andrews RE; Miller O; Rosenthal E; Sharland GK; Simpson JM
    Heart Rhythm; 2014 Nov; 11(11):2047-53. PubMed ID: 25068572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B
    Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Digoxin. The drug of choice for the in-utero treatment of paroxysmal supraventricular tachycardia].
    Silva IS; Nunes C; Mimoso G; Castela E; Mesquita J
    Acta Med Port; 1997 Jan; 10(1):95-8. PubMed ID: 9245185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal ultrasound may predict fetal response to therapy in non-hydropic fetuses with supraventricular tachycardia.
    Jouannic JM; Le Bidois J; Fermont L; Villain E; Mahieu-Caputo D; Dumez Y; Dommergues M
    Fetal Diagn Ther; 2002; 17(2):120-3. PubMed ID: 11844918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Protocols for the treatment of supraventricular tachycardias in the fetus].
    Oudijk MA; Ambachtsheer EB; Stoutenbeek P; Meijboom EJ
    Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1218-9. PubMed ID: 11447879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes of venous blood flow velocity waveforms in fetuses with supraventricular tachycardia.
    Gembruch U; Krapp M; Baumann P
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):394-9. PubMed ID: 7552801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate-based management of fetal supraventricular tachycardia.
    Guntheroth WG; Cyr DR; Shields LE; Nghiem HV
    J Ultrasound Med; 1996 Jun; 15(6):453-8. PubMed ID: 8738990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.